-Syusei Tominaga Researcher Activity Profile

Research Author Detailed Information 

Syusei Tominaga Publication Rate By Year

Syusei Tominaga has published 2 paper(s) in 1983, 1 paper(s) in 1986, 1 paper(s) in 1997, 2 paper(s) in 1999, 1 paper(s) in 2001, 1 paper(s) in 2002, 1 paper(s) in 2005, 16 paper(s) in 2007, for a total of 25 research publications in total.

Syusei S Tominaga Author Information

LAST NAME: tominaga

FIRST NAME: Syusei

INITIALS: s

AFFILIATION:

Papers

Syusei Tominaga's Publication Record

1. A case of metastatic lobular breast carcinoma with detection of the primary tumor after ten years. Year Published: 2007
Department of Surgery, Ikeda Municipal Hospital, Ikeda, Osaka, Japan. tkoba99@infoweb.ne.jp
2. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice. Year Published: 2007
Department of Respiratory Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan. cri@med.juntendo.ac.jp
3. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract. Year Published: 2007
Department of Pathology and Laboratory Medicine, National Defense Medical College, Tokorozawa, 359-8513, Japan, nknsknak@ndmc.ac.jp.
4. A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice. Year Published: 2007
Mouse Functional Genomics Research Group, RIKEN GSC, Tsukuba, Ibaraki, Japan. hmasuya@gsc.riken.jp
5. Thirteen-week repeated dose oral toxicity study of coenzyme Q10 in rats. Year Published: 2007
6. A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer. Year Published: 2007
Minoh City Hospital, 5-7-1 Kayano, Minoh City, Osaka, 562-8562, Japan.
7. Growth hormone has dual stage-specific effects on the differentiation of 3T3-L1 preadipocytes. Year Published: 2002
Department of Life Science, Graduate School of Science, Himeji Institute of Technology, Koto, Kamigori, Hyogo 678-1297, Japan.
8. Adenosine triphosphatases associated with bovine brain microtubules. I. Presence of two distinct ATPases and their partial purification. Year Published: 1983
9. Adenosine triphosphatases associated with bovine brain microtubules. II. Properties of ATPases I and II. Year Published: 1983
10. The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells. Year Published: 1997
Department of Biochemistry II, Jichi Medical School, Tochigi.
11. Opposite regulation of the expression of cyclin-dependent kinase inhibitors during contact inhibition. Year Published: 1999
Department of Biochemistry, Jichi Medical School, Yakushiji, Minamikawachi-machi, Tochigi 329-0498, Japan. kenyanag@jichi.ac.jp
12. Functional role of c-Src in IL-1-induced NF-kappa B activation: c-Src is a component of the IKK complex. Year Published: 2005
Department of Biochemistry and Immunology, Kyoritsu University of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512.
13. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice. Year Published: 2007
Department of Respiratory Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan. cri@med.juntendo.ac.jp
14. Thirteen-week repeated dose oral toxicity study of coenzyme Q10 in rats. Year Published: 2007
15. First Stereoselective Synthesis of meso-Secoisolariciresinol and Comparison of Its Biological Activity with (+) and (-)-Secoisolariciresinol. Year Published: 2007
Faculty of Agriculture, Ehime University.
16. First stereoselective synthesis of meso-secoisolariciresinol and comparison of its biological activity with (+) and (-)-secoisolariciresinol. Year Published: 2007
Faculty of Agriculture, Ehime University, Matsuyama, Ehime, Japan.
17. A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer. Year Published: 2007
Minoh City Hospital, 5-7-1 Kayano, Minoh City, Osaka 562-8562, Japan. takeshi_kato@maple.city.minoh.lg.jp
18. A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha. Year Published: 2001
Department of Biochemistry and Immunology, Kyoritsu College of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
19. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract. Year Published: 2007
Department of Pathology and Laboratory Medicine, National Defense Medical College, Tokorozawa, 359-8513, Japan. nknsknak@ndmc.ac.jp
20. A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer. Year Published: 2007
Minoh City Hospital, 5-7-1 Kayano, Minoh City, Osaka 562-8562, Japan. takeshi_kato@maple.city.minoh.lg.jp
21. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract. Year Published: 2007
Department of Pathology and Laboratory Medicine, National Defense Medical College, Tokorozawa, 359-8513, Japan. nknsknak@ndmc.ac.jp
22. A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice. Year Published: 2007
Mouse Functional Genomics Research Group, RIKEN GSC, Tsukuba, Ibaraki, Japan. hmasuya@gsc.riken.jp
23. Human papillomavirus as a risk factor for head and neck cancers--a case-control study. Year Published: 1999
Department of Otolaryngology, Okayama University Medical School, Japan.
24. [Surgical treatment of dissecting aneurysms] Year Published: 1986
25. First stereoselective synthesis of meso-secoisolariciresinol and comparison of its biological activity with (+) and (-)-secoisolariciresinol. Year Published: 2007
Faculty of Agriculture, Ehime University, Matsuyama, Ehime, Japan.